rs80358261
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM2PP3
The NM_006432.5(NPC2):c.115G>A(p.Val39Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000262 in 1,602,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. V39V) has been classified as Likely benign.
Frequency
Consequence
NM_006432.5 missense
Scores
Clinical Significance
Conservation
Publications
- Niemann-Pick disease, type C2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Niemann-Pick disease type C, adult neurologic onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Niemann-Pick disease type C, juvenile neurologic onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Niemann-Pick disease type C, late infantile neurologic onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Niemann-Pick disease type C, severe early infantile neurologic onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Niemann-Pick disease type C, severe perinatal formInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPC2 | NM_006432.5 | c.115G>A | p.Val39Met | missense_variant | Exon 2 of 5 | ENST00000555619.6 | NP_006423.1 | |
NPC2 | NM_001363688.1 | c.115G>A | p.Val39Met | missense_variant | Exon 2 of 4 | NP_001350617.1 | ||
NPC2 | NM_001375440.1 | c.115G>A | p.Val39Met | missense_variant | Exon 2 of 4 | NP_001362369.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000174 AC: 4AN: 229918 AF XY: 0.0000243 show subpopulations
GnomAD4 exome AF: 0.0000276 AC: 40AN: 1449990Hom.: 0 Cov.: 31 AF XY: 0.0000264 AC XY: 19AN XY: 719790 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74340 show subpopulations
ClinVar
Submissions by phenotype
Niemann-Pick disease, type C2 Pathogenic:1Uncertain:1Other:1
- -
- -
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 39 of the NPC2 protein (p.Val39Met). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with Niemann–Pick disease type C (PMID: 12447927). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8483). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change does not substantially affect NPC2 function (PMID: 15937921). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
NPC2-related disorder Uncertain:1
The NPC2 c.115G>A variant is predicted to result in the amino acid substitution p.Val39Met. This variant was reported in the homozygous state in two sisters who presented in middle age with dementia and hallucinations (Klunemann et al. 2002. PubMed ID: 12447927). In functional studies, the p.Val39Met substitution was reported to result in functionally normal NPC2 protein (Chikh et al. 2005. PubMed ID: 15937921). This variant is reported in 0.0039% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at